Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward Roberts

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
Molecular Phylogenetics and Evolution|August 30, 2020
An enhanced target-enrichment bait set for Hexacorallia provides phylogenomic resolution of the staghorn corals (Acroporidae) and close relativesPeter F Cowman, Andrea M Quattrini, Tom C L Bridge, et al.
Bioorganic & Medicinal Chemistry Letters|October 6, 2009
N,N-Diethyl-4-[(3-hydroxyphenyl)(piperidin-4-yl)amino] benzamide derivatives: the development of diaryl amino piperidines as potent delta opioid receptor agonists with in vivo anti-nociceptive activity in rodent modelsPaul Jones, Andrew M Griffin, Lars Gawell, et al.
Journal of Medicinal Chemistry|February 2, 2019
Design and Synthesis of a Novel and Selective Kappa Opioid Receptor (KOR) Antagonist (BTRX-335140)Miguel Guerrero, Mariangela Urbano, Eun-Kyong Kim, et al.
Neuroimage. Clinical|March 24, 2017
Altered functional brain connectivity in patients with visually induced dizzinessAngelique Van Ombergen, Lizette Heine, Steven Jillings, et al.
Blood Advances|February 14, 2022
Metalloproteinase inhibition reduces AML growth, prevents stem cell loss, and improves chemotherapy effectivenessChiara Pirillo, Flora Birch, Floriane S Tissot, et al.
European Journal of Pharmacology|February 6, 2010
KR-003048, a potent, orally active inhibitor of p38 mitogen-activated protein kinaseAntonio Garrido Montalban, Erik Boman, Chau-Dung Chang, et al.
Bioorganic & Medicinal Chemistry Letters|March 8, 2008
The design and synthesis of novel alpha-ketoamide-based p38 MAP kinase inhibitorsAntonio Garrido Montalban, Erik Boman, Chau-Dung Chang, et al.
Nature Communications|September 27, 2023
Lung extracellular matrix modulates KRT5<sup>+</sup> basal cell activity in pulmonary fibrosisRichard J Hewitt, Franz Puttur, David C A Gaboriau, et al.
Bioorganic & Medicinal Chemistry Letters|July 29, 2010
Optimization of alpha-ketoamide based p38 inhibitors through modifications to the region that binds to the allosteric siteAntonio Garrido Montalban, Erik Boman, Chau-Dung Chang, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 18, 2016
Genetic and Pharmacologic Manipulation of TLR4 Has Minimal Impact on Ethanol Consumption in RodentsR Adron Harris, Michal Bajo, Richard L Bell, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Molecular Phylogenetics and Evolution|August 30, 2020
An enhanced target-enrichment bait set for Hexacorallia provides phylogenomic resolution of the staghorn corals (Acroporidae) and close relativesPeter F Cowman, Andrea M Quattrini, Tom C L Bridge, et al.
Bioorganic & Medicinal Chemistry Letters|October 6, 2009
N,N-Diethyl-4-[(3-hydroxyphenyl)(piperidin-4-yl)amino] benzamide derivatives: the development of diaryl amino piperidines as potent delta opioid receptor agonists with in vivo anti-nociceptive activity in rodent modelsPaul Jones, Andrew M Griffin, Lars Gawell, et al.
Journal of Medicinal Chemistry|February 2, 2019
Design and Synthesis of a Novel and Selective Kappa Opioid Receptor (KOR) Antagonist (BTRX-335140)Miguel Guerrero, Mariangela Urbano, Eun-Kyong Kim, et al.
Neuroimage. Clinical|March 24, 2017
Altered functional brain connectivity in patients with visually induced dizzinessAngelique Van Ombergen, Lizette Heine, Steven Jillings, et al.
Blood Advances|February 14, 2022
Metalloproteinase inhibition reduces AML growth, prevents stem cell loss, and improves chemotherapy effectivenessChiara Pirillo, Flora Birch, Floriane S Tissot, et al.
European Journal of Pharmacology|February 6, 2010
KR-003048, a potent, orally active inhibitor of p38 mitogen-activated protein kinaseAntonio Garrido Montalban, Erik Boman, Chau-Dung Chang, et al.
Bioorganic & Medicinal Chemistry Letters|March 8, 2008
The design and synthesis of novel alpha-ketoamide-based p38 MAP kinase inhibitorsAntonio Garrido Montalban, Erik Boman, Chau-Dung Chang, et al.
Nature Communications|September 27, 2023
Lung extracellular matrix modulates KRT5<sup>+</sup> basal cell activity in pulmonary fibrosisRichard J Hewitt, Franz Puttur, David C A Gaboriau, et al.
Bioorganic & Medicinal Chemistry Letters|July 29, 2010
Optimization of alpha-ketoamide based p38 inhibitors through modifications to the region that binds to the allosteric siteAntonio Garrido Montalban, Erik Boman, Chau-Dung Chang, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 18, 2016
Genetic and Pharmacologic Manipulation of TLR4 Has Minimal Impact on Ethanol Consumption in RodentsR Adron Harris, Michal Bajo, Richard L Bell, et al.
Pageof 9